Drug Screening Core

Drug Screening Core

Drug Screening Core provides molecule design, screen and optimization for drug development, as well as tailored treatment relevant to personalized medicine in clinic practice, with a particular focus on oncology, cardiovascular and metabolic diseases. Equipped with a variety of target-specific compounds library, and self-designed automat- ed drug screening workstations, our core routinely conducts comprehensive drug optimi- zation and evaluation. With integrated systems pharmacology, structure-based parallel medicinal and computational chemistry technology, we are able to perform drug development research at the molecular, cellular and orgasm levels. Meanwhile, we use target-known compounds as chemical probes to decipher disease-related signaling pathways.

Director: Zhang Jianming

Automated Drug Screening

Key Equipment: Automatic liquid handler, ultrasensitive microplate detection system, multi parameter high-content analysis system.

Services:

  • High throughput screening on biochemical at cellular and model organism level

  • Custom-made compound library

Drug Optimization

Key Equipment: High diversity compound library, Virtual screening system, Medicinal chemistry.

Services:

  • Synthesis of organic compound/probe

  • lead compound optimization

  • patent application

Preclinical Efficacy Evaluation

Key Equipment: Custom protein expression and purification system, molecular interaction analyz- er, cell and tissue culture system.

Services:

  • Pharmacokinetic and pharmacodynamics evaluation

Preclinical Efficacy Evaluation

Key Equipment: High performance liquid chromatography, high resolution mass spectrometer, nucle- ar magnetic resonance spectrometer.

Services:

  • Drug analysis

  • pharmacology and toxicology research

  • DMPK

  • Identification of metabolites

Contact

Zhang Qianqian

Email: zhangqianmengjie@outlook.com